Attachment B - 60 day FRN

24705

Federal Register / Vol. 75, No. 86 / Wednesday, May 5, 2010 / Notices
demand for accurate information about
rates of screening, referral, loss to
follow-up, and prevalence. This
information is important for: (a) Helping
to ensure infants and children are
receiving recommended screening and
follow-up services, (b) identifying
reasons for not receiving recommended
services and (c) documenting the
occurrence of differing degrees of HL
among infants. These data will also
assist the States in Early Hearing
Detection and Intervention (EHDI)
programs with quality improvement
activities and provide information that
will be helpful in assessing the impact

of Federal initiatives. The public will be
able to access this information via the
CDC EHDI Web site (http://
www.cdc.gov/ncbddd/ehdi).
Given the lack of a standardized and
readily accessible source of data, the
CDC EHDI program developed a survey
to be used annually that utilizes
uniform definitions to collect aggregate,
standardized EHDI data from States and
territories. The request to complete this
survey is planned to be disseminated to
57 respondents via an e-mail, which
will include a summary of the request
and other relevant information. We
anticipate that about 50 of the 57

coordinators will complete and return
the survey. Minor changes to this
survey, based on respondent feedback,
are planned in order to make the survey
easier to complete and further improve
data quality. These changes include
adding a question about how many
infants with hearing loss are receiving
only monitoring services, simplifying
the table for reporting type and severity
of hearing loss data, and expanding the
maternal race categories in the
demographic section. There are no costs
to the respondents other than their time.
The estimated annualized burden hours
are 210.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Respondents

EHDI Program State Program Coordinators Contacted .............................................................
EHDI Program State Program Coordinators Who Return the Survey ........................................

Dated: April 28, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–10587 Filed 5–4–10; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–10–10CV]

sroberts on DSKD5P82C1PROD with NOTICES

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects.
Alternatively, to obtain a copy of the
data collection plans and instrument,
call 404–639–5960 and send comments
to Maryam I. Daneshvar, CDC Reports
Clearance Officer, 1600 Clifton Road,
NE., MS–D74, Atlanta, Georgia 30333;
comments may also be sent by e-mail to
[email protected].
Comments are invited on (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the

VerDate Mar<15>2010

19:02 May 04, 2010

Jkt 220001

proposed collection of information; (c)
ways to enhance the quality, utility, and
clarify of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of information technology. Written
comments should be received within 60
days of this notice.
Proposed Project
Early Aberration Reporting System
(EARS) Registration Module—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID)
(proposed), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
To support two of CDC’s main priority
areas: (1) Improving CDC’s support for
state and local health departments, and
(2) strengthening surveillance and
epidemiology, CDC is requesting
approval from the Office of Management
and Budget (OMB) to improve the Early
Aberration Reporting System (EARS) by
collecting data from individuals who
request a download of EARS from the
CDC website.
The Early Aberration Reporting
System, developed within the Division
of Bioterrorism Preparedness and
Response, is a web-enabled tool that
analyzes public health surveillance data
using methods that detect abnormal
trends that could possibly indicate an
outbreak of infectious disease. The local
public health professionals manage the
entire tool and can implement the
defaults or can adjust the tool in order
to meet their local needs. The goal of

PO 00000

Frm 00138

Fmt 4703

Sfmt 4703

57
50

Number of responses per
respondent
1
1

Average
burden per
response
(in hours)
10/60
4

this process is to assist public health
professionals in the early identification
of outbreaks of disease as well as
bioterrorism events. EARS is used to
assess whether the current number of
reported cases of an event is higher than
usual.
The term syndromic surveillance is
used to describe surveillance that uses
health-related data that precede
diagnosis and that signals a sufficient
probability of a case or an outbreak of
infectious disease to warrant further
public health response. Syndromic
surveillance systems are used by state,
local, national and international health
departments to monitor syndrome-based
(e.g., case information collected in
emergency departments (EDs) and
diagnostic data sources for early
detection of outbreaks and other public
health events). More recently these
systems are used during public health
responses to provide more rapid near
real-time situational awareness
regarding the health status of the target
population. EARS was the first software
platform to support local syndromic
surveillance systems. EARS has been
designed and used to monitor
syndromic data from emergency
departments, 911 calls, physician office
data, school and business absenteeism,
over-the-counter drug sales, laboratory
testing and results data and reportable
disease surveillance systems. In the past
several years, EARS systems have been
integral in the local public health
surveillance arsenal. EARS has been
used at events such as the Beijing
Summer Olympics; multiple

E:\FR\FM\05MYN1.SGM

05MYN1

24706

Federal Register / Vol. 75, No. 86 / Wednesday, May 5, 2010 / Notices

Superbowls (football) and World Series
(baseball); the political conventions of
both major US political parties; and the
Presidential Inauguration (2009).
Today, EARS is a highly successful
and sustainable system and has over 200
users at the Federal, State, local, and
international levels. These users include
international Ministries of Health and
domestic state and local public health
departments. Additionally, EARS
detection methods have been integrated
in well-known surveillance platforms
such as BioSense at CDC, ESSENSE at
Johns Hopkins, NAMRD at US

contact information (i.e., e-mail
addresses) to use for broadcast e-mails
regarding new releases for upgrades and
enhancements; track the number of
users, the download frequency, and the
type of data that users will monitor with
EARS; and solicit users for feedback for
future upgrades and enhancements.
CDC estimates that there will be 150
respondents registered for EARS. Each
respondent will need an average of 10
minutes to complete the EARS
registration form which leads to a total
public burden of 25 hours.
There is no cost to respondents to
participate in this program.

Department of Defense, and Emergint at
Northrop Grumman.
EARS is widely-accepted and easily
sustainable due to its being free to all
end users, the capacity to use multiple
forms of data, flexibility and user-driven
design and maintenance. EARS is a
service provided by CDC as share-ware
and is available by download at no cost
from the CDC Web site http://
www.bt.cdc.gov/surveillance/EARS.
In an effort to continue to improve
and enhance EARS, the collection of
registration information is needed to
track users and organizations to assist in
future needs assessments. Requiring the
users to register will provide CDC with

ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents

Respondents

Users ................................................................................................................

Centers for Disease Control and
Prevention (CDC).

[FR Doc. 2010–10586 Filed 5–4–10; 8:45 am]

This data collection is based on the
following components of the Public
Health Service Act: (1) Act 42 U.S.C.
241, Section 301, which authorizes
‘‘research, investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases and impairments of man.’’ (2)
42 U.S.C. 247b–4, Section 317 C, which
authorizes the activities of the National
Center on Birth Defects and
Developmental Disabilities. This section
was created by Public Law 106–310,
also known as ‘‘the Children’s Health
Act of 2000.’’ This portion of the code
has also been amended by Public Law
108–154, which is also known as the
‘‘Birth Defects and Developmental
Disabilities Prevention Act of 2003.’’
The Children’s Health Act of 2000
mandated CDC to establish autism
surveillance and research programs to
address the number, incidence,
correlates, and causes of autism and
related disabilities. Under the
provisions of this act, CDC funded five
Centers for Autism and Developmental
Disabilities Research and Epidemiology
(CADDRE) including the California
Department of Health and Human
Services, Colorado Department of Public
Health and Environment, Johns Hopkins
University, the University of
Pennsylvania, and the University of
North Carolina at Chapel Hill. CDC
National Center on Birth Defects and

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–10–0741]

Agency Forms Undergoing Paperwork
Reduction Act Review

sroberts on DSKD5P82C1PROD with NOTICES

150

Dated: April 21, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
BILLING CODE 4163–18–P

The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call Maryam I. Daneshvar, the
CDC Reports Clearance Officer, at (404)
639–5960 or send an e-mail to
[email protected]. Send written comments
to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
The Study to Explore Early
Development (SEED) (OMB No. 0920–
0741 exp. 6/30/2010)—Revision—
National Center on Birth Defects and
Developmental Disabilities (NCBDDD),

VerDate Mar<15>2010

19:02 May 04, 2010

Jkt 220001

Background and Brief Description

PO 00000

Frm 00139

Fmt 4703

Sfmt 4703

Number of
responses per
respondent
1

Average burden per
response
(in hours)
10/60

Total
burden
(in hours)
25

Developmental Disabilities participates
as the sixth CADDRE site. The SEED
multi-site, collaborative project is an
epidemiological investigation of
possible causes for the autism spectrum
disorders.
Study participants are to be selected
from children born in and residing in
the following six areas: Atlanta
metropolitan area, San Francisco Bay
area, Denver metropolitan area,
Baltimore metropolitan area,
Philadelphia metropolitan area, and
Central North Carolina. Children with
autism spectrum disorders are
compared to children with other
developmental problems, referred to as
the neurodevelopmentally impaired
group (NIC), as well as children who do
not have developmental problems,
referred to as the sub-cohort.
Data collection methods consist of the
following: (1) Medical record review of
the child participant; (2) medical record
review of the biological mother of the
child participant; (3) packets sent to the
participants with self-administered
questionnaires and a buccal swab kit; (4)
a telephone interview focusing on
pregnancy-related events and early life
history (biological mother and/or
primary caregiver interview); (5) a child
development evaluation (more
comprehensive for case participants
than for the control group participants);
(6) parent-child development interview
(for case participants only) administered
over the telephone or in-person; (7) a
physical exam of the child participant;
(8) biological sampling of the child
participant (blood and hair); and, (9)

E:\FR\FM\05MYN1.SGM

05MYN1